| Not Yet Recruiting | Assessment of Sexual Quality of Life Following Local Treatment (Radiotherapy With or Without Surgery) in Patie NCT07523152 | Institut du Cancer de Montpellier - Val d'Aurelle | N/A |
| Recruiting | DESTINY-PANTUMOUR04 NCT07124000 | AstraZeneca | — |
| Recruiting | E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated Cancers NCT05639972 | Christian Hinrichs | Phase 1 / Phase 2 |
| Recruiting | Belzutifan in Recurrent Clear Cell Carcinoma of Gynecologic Origin NCT06677190 | Dana-Farber Cancer Institute | Phase 2 |
| Completed | Enhanced Assistance During Radiotherapy for Unmet Essential Needs NCT06582849 | Washington University School of Medicine | N/A |
| Recruiting | The Gynecological Cancer Associated Thrombosis (GynCAT) Study NCT06284343 | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | — |
| Recruiting | ASk Questions in GYnecologic Oncology (ASQ-GYO) NCT06339827 | Ira Winer | N/A |
| Recruiting | Radiochemotherapy and Interventional Radiotherapy in Vaginal Cancer NCT06314568 | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | — |
| Recruiting | 3D Printed Custom Applicators for HDR BT (DISCO) NCT06432478 | Royal North Shore Hospital | N/A |
| Recruiting | Using Reiki Therapy to Improve Symptoms Associated With Brachytherapy in Patients With Gynecological Malignanc NCT05979610 | University of Utah | Phase 2 |
| Recruiting | Physical Activity Intervention Among Older Women With Gynecologic Cancers (Fit4Treatment) NCT05743517 | Northwestern University | N/A |
| Recruiting | SCG142 TCR-T Cells for Human Papillomavirus-Associated Carcinomas NCT06544720 | The Affiliated Hospital of Qingdao University | Phase 1 |
| Completed | Study of a Rapid Triadic Communication Intention Elicitation Intervention to Improve Supportive Oncology Care NCT05995860 | Indiana University | N/A |
| Active Not Recruiting | Long-term Follow-up of Bivalent Human Papillomavirus (HPV) Vaccine Study in Women NCT06776055 | Shanghai Zerun Biotechnology Co.,Ltd | — |
| Recruiting | E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers NCT05686226 | Christian Hinrichs | Phase 2 |
| Recruiting | NYSCF Scientific Discovery Biobank NCT06203106 | New York Stem Cell Foundation Research Institute | — |
| Unknown | Gynaecology Exercise and Mindfulness Study NCT05561413 | University of Ulster | N/A |
| Recruiting | Immune Persistence After the Whole Vaccination Shcedule With Recombination Quadrivalent HPV Vaccine NCT05371353 | Shanghai Bovax Biotechnology Co., Ltd. | — |
| Recruiting | Retrospective Study of Brachytherapy NCT05242861 | Zhejiang Cancer Hospital | — |
| Terminated | Primary Organoid Models and Combined Nucleic Acids Therapeutics for Anti-HPV Treatments NCT04278326 | Centre Hospitalier Régional d'Orléans | N/A |
| Active Not Recruiting | A Phase I/II Study of Combination Immunotherapy for Advanced Cancers Including HPV-Associated Malignancies, Sm NCT04708470 | National Cancer Institute (NCI) | Phase 1 / Phase 2 |
| Recruiting | Immunogenicity and Safety of Quadrivalent HPV Vaccine in Healthy Chinese Female Subjects Aged 9 to 19 Years NCT05027776 | Shanghai Bovax Biotechnology Co., Ltd. | Phase 3 |
| Recruiting | Immunobridging Study of 9-valent Human Papillomavirus Recombinant Vaccine in Chinese Females Aged 9 to 19 Year NCT04895020 | Shanghai Bovax Biotechnology Co., Ltd. | Phase 3 |
| Completed | The Registry of Oncology Outcomes Associated With Testing and Treatment NCT04028479 | Taproot Health | — |
| Completed | Relational Agents in Cervical Cancer Education (RACE) NCT06537687 | Radhika Gogoi | N/A |
| Completed | Evaluate the Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females NCT05372016 | Shanghai Bovax Biotechnology Co., Ltd. | Phase 3 |
| Completed | Effect of Irradiation Doses < 10 Gy and of Irradiated Bone Volume on the Variation of Blood Elements of the Co NCT04626466 | Institut de cancérologie Strasbourg Europe | — |
| Completed | Evaluate the Immunogenicity and Safety of 4-valent and 9-valent HPV Recombinant Vaccine in Chinese Healthy Fem NCT04425291 | Shanghai Bovax Biotechnology Co., Ltd. | Phase 3 |
| Recruiting | Evaluate the Efficacy, Immunogenicity and Safety of 9-valent HPV Recombinant Vaccine in Chinese Healthy Female NCT04422366 | Shanghai Bovax Biotechnology Co., Ltd. | Phase 3 |
| Completed | Impact of a Sexological Follow-up on the Sexual Function in Patients With Cervix or Vaginal Cancer Treated by NCT03956498 | Institut Claudius Regaud | N/A |
| Completed | Evaluate the Safety and Primary Immunogenicity of 9-valent HPV Recombinant Vaccine in Chinese Healthy Females NCT03676101 | Shanghai Bovax Biotechnology Co., Ltd. | Phase 1 |
| Completed | Integrating a Health Information Technology System for Primary and Secondary Cervical Cancer Prevention NCT03346915 | Boston Medical Center | N/A |
| Unknown | Sexual Rehabilitation Programme After Radiotherapy for Gynaecological Cancer NCT03611517 | Leiden University Medical Center | N/A |
| Completed | Immunogenicity and Tolerability of Broad Spectrum Human Papillomavirus (HPV) Vaccine in Adult and Young Adult NCT03158220 | Merck Sharp & Dohme LLC | Phase 3 |
| Recruiting | Image-Guided Gynecologic Brachytherapy NCT02993900 | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | N/A |
| Completed | MR-HIFU for Recurrent Gynaecological Cancer NCT02714621 | Institute of Cancer Research, United Kingdom | N/A |
| Active Not Recruiting | Long-term Follow-up of Broad Spectrum Human Papillomavirus (HPV) Vaccine Study in Women (V503-021) NCT02653118 | Merck Sharp & Dohme LLC | — |
| Unknown | Developing a Stepped Approach to Improving Sexual Function aFteR Treatment fOr gyNaecological Cancer NCT02458001 | University College, London | N/A |
| Completed | T Cell Receptor Immunotherapy Targeting HPV-16 E6 for HPV-Associated Cancers NCT02280811 | National Cancer Institute (NCI) | Phase 1 / Phase 2 |
| Completed | Phone or Email Reminder in Increasing Vaginal Dilator Use in Patients With Gynecologic Cancers Undergoing Brac NCT02058550 | Stanford University | Phase 1 |
| Completed | Scripted Sexual Health Informational Intervention in Improving Sexual Function in Patients With Gynecologic Ca NCT02096783 | University of Wisconsin, Madison | N/A |
| Recruiting | Integrated Cancer Repository for Cancer Research NCT02012699 | University of Nebraska | — |
| Completed | Magnetic Resonance Imaging of Gynecologic Malignancies Involving the Vagina NCT01703195 | M.D. Anderson Cancer Center | N/A |
| Completed | Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Human Papillomavirus-Associate NCT01585428 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Image-Guided Gynecologic Brachytherapy NCT01399658 | Dana-Farber Cancer Institute | Phase 2 |
| Completed | A Survivorship Care Plan for Gynaecological Cancer Patients NCT01582906 | Royal Marsden NHS Foundation Trust | — |
| Completed | Validation of a Nutrition Screening Tool NCT01851928 | Royal Marsden NHS Foundation Trust | — |
| Completed | Study of Physical and Psychosocial Rehabilitation Needs of Patients After Diagnosis and Treatment of Upper Gas NCT01216813 | Royal Marsden NHS Foundation Trust | — |
| Withdrawn | Examining the Role of Transrectal High Intensity Focused Ultrasound (HIFU) in Rectal Pelvic Cancer NCT01097239 | Imperial College London | Phase 1 / Phase 2 |
| Completed | A Study of V503 (A Multivalent Human Papillomavirus [HPV] L1 Virus-Like Particle [VLP] Vaccine) in Preadolesce NCT00943722 | Merck Sharp & Dohme LLC | Phase 3 |
| Completed | Gynecologic Cancer Lymphedema Questionnaire as a Clinical Care Tool to Identify Lower Extremity Lymphedema NCT00944944 | Memorial Sloan Kettering Cancer Center | — |
| Completed | Outcomes From Home in Patients Recovering From Major Gynecologic Cancer Surgery: Measuring Symptoms and Health NCT00870233 | Memorial Sloan Kettering Cancer Center | — |
| Completed | Topotecan in Treating Patients With Gynecologic Cancer That Cannot Be Removed by Surgery NCT00842452 | Steven Waggoner, MD | Phase 1 |
| Unknown | Hyperbaric Oxygen Therapy in Treating Long-Term Gastrointestinal Adverse Effects Caused by Radiation Therapy i NCT01087268 | Royal Marsden NHS Foundation Trust | Phase 3 |
| Unknown | Pelvic Fractures and Radiation Therapy for Cervical Cancer NCT00800644 | M.D. Anderson Cancer Center | — |
| Unknown | Nutritional Supplements in Improving Quality of Life During First-Line Chemotherapy in Patients With Metastati NCT00905658 | Centre Oscar Lambret | Phase 2 |
| Completed | A Study to Evaluate Tolerability and Immunogenicity of V504 Administered Concomitantly With GARDASIL (V504-001 NCT00551187 | Merck Sharp & Dohme LLC | Phase 2 |
| Completed | Broad Spectrum HPV (Human Papillomavirus) Vaccine in 16 to 26 Year Old Women (V505-001) NCT00520598 | Merck Sharp & Dohme LLC | Phase 2 |
| Completed | Broad Spectrum HPV (Human Papillomavirus) Vaccine Study in 16-to 26-Year-Old Women (V503-001) NCT00543543 | Merck Sharp & Dohme LLC | Phase 3 |
| Completed | Safety Study Of Avastin And Pelvic Radiation In Women With Recurrent Gynecological Cancers NCT00545792 | Dana-Farber Cancer Institute | Phase 2 |
| Completed | Fondaparinux in Preventing Blood Clots in Patients Undergoing Surgery for Gynecologic Cancer NCT00381888 | Masonic Cancer Center, University of Minnesota | Phase 2 |
| Terminated | ChemoFx® PRO - A Post-Market Data Collection Study NCT00669422 | Precision Therapeutics | — |
| Completed | Study of Psychosexual Impact of Cancer-Related Infertility in Women: Third Party Reproductive Assistance NCT00581646 | Memorial Sloan Kettering Cancer Center | — |
| Completed | Broad Spectrum HPV Vaccine Dose Escalation Study (V502-002) NCT00851643 | Merck Sharp & Dohme LLC | Phase 1 |
| Unknown | Study of DNA Mutations in Predicting the Effect of External-Beam Radiation Therapy in Patients With Early Brea NCT00601406 | The Christie NHS Foundation Trust | N/A |
| Withdrawn | Capecitabine and Radiation Therapy in Treating Patients With Locally Advanced Cervical Cancer or Other Pelvic NCT00118300 | Case Comprehensive Cancer Center | Phase 1 |
| Completed | Internet-based System for Cancer Patients to Self-report Toxicity NCT00578006 | Memorial Sloan Kettering Cancer Center | N/A |
| Completed | Docetaxel in Treating Patients With Refractory or Recurrent Advanced Gynecologic Cancer NCT00287885 | Masonic Cancer Center, University of Minnesota | Phase 1 |
| Completed | Effectiveness of an Individualized Symptom Education Program (ISEP) NCT00275353 | University of Toronto | Phase 2 |
| Completed | Lymphoscintigraphy in Patients With Vaginal Cancer NCT00528034 | M.D. Anderson Cancer Center | N/A |
| Completed | Octreotide in Preventing Diarrhea in Patients Who Are Undergoing Radiation Therapy to the Pelvis NCT00033605 | Alliance for Clinical Trials in Oncology | Phase 3 |
| Completed | Immediate Vaginal Reconstruction After Oncologic Resection: Surgical Outcomes, Patient Satisfaction and Sexual NCT00588081 | Memorial Sloan Kettering Cancer Center | N/A |
| Recruiting | Specimen and Data Study for Ovarian Cancer Early Detection and Prevention NCT00005095 | Northwestern University | — |
| Completed | Peripheral Stem Cell Transplant, White Blood Cell Infusions, Chemotherapy, and Radiation Therapy in Treating P NCT00005941 | Fred Hutchinson Cancer Center | Phase 2 |
| Completed | Pelvic Drains After Radical Hysterectomy in Treating Patients With Uterine, Cervical, or Vaginal Cancer NCT00003267 | European Organisation for Research and Treatment of Cancer - EORTC | Phase 3 |
| Completed | Vinorelbine and Paclitaxel Plus Radiation Therapy in Treating Patients With Advanced Cancer Arising in the Pel NCT00002949 | University of Chicago | Phase 1 |
| Completed | Paclitaxel in Treating Patients With Advanced, Refractory, or Recurrent Cervical or Vaginal Cancer NCT00002562 | Gynecologic Oncology Group | Phase 2 |